Monday, 31 August 2026European Markets

FOUNTAIN Stock Impressive Rise Before The Weekend, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with FOUNTAIN (FOU.BR) jumping 12.3% to €1.37 on Friday while BEL 20 jumped 0.05% to €3,959.84.

About FOUNTAIN

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in in France, Belgium, the Netherlands, and rest of European Countries. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was incorporated in 1972 and is based in Braine l'Alleud, Belgium.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of €0.18.

PE Ratio

FOUNTAIN has a trailing twelve months price to earnings ratio of 7.61. Meaning, the purchaser of the share is investing €7.61 for every euro of annual earnings.

Volatility

FOUNTAIN's last week, last month's, and last quarter's current intraday variation average was a negative 5.70%, a negative 2.26%, and a positive 3.58%.

FOUNTAIN's highest amplitude of average volatility was 5.70% (last week), 5.34% (last month), and 3.58% (last quarter).

Volume

Today's last reported volume for FOUNTAIN is 150 which is 87.11% below its average volume of 1164.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FOUNTAIN's stock is considered to be overbought (>=80).

More news about FOUNTAIN (FOU.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com